SARS-COV-2 Spike S1 (D614G) Protein (COV-VM4SG)

KACTUS

SARS-COV-2 Spike S1 (D614G) Protein (COV-VM4SG)

9

Research Use Only

>95%

The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

-20°C or -80°C,-80°C

12352202